NCT01995188 2017-10-04A Study to Evaluate the Safety and Pharmacology of DNIB0600A in Participants With Platinum-Sensitive Ovarian Cancer or Non-Squamous Non-small Cell Lung CancerGenentech, Inc.Phase 1 Completed41 enrolled
NCT01363947 2017-06-07Safety and Pharmacokinetics of Escalating Doses of DNIB0600A in Participants With Non-Small Cell Lung Cancer (NSCLC) and Platinum Resistant Ovarian CancerGenentech, Inc.Phase 1 Completed87 enrolled